New Tests Launched in February - Insights

In February 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in January - Insights

In January 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New Tests Launched in October - Insights

In October 2018, Mayo Medical Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Anticoagulant drug monitoring - Insights

Browse our growing menu of special coagulation drug assays designed for both routine monitoring and select clinical situations.

Sarcoma Pathology Consultation - Mayo Clinic Laboratories

For cases needing an added level of support, our second-opinion pathology consultations are conducted by a team of pathologists who are experts in bone and soft tissue pathology.

Neuropathology Consultations - Mayo Clinic Laboratories

Our second-opinion consultations give neuropathologists access to Mayo Clinic neuropatholgists who can help choose the most appropriate molecular and cytogenetic testing.

Thrombophilia testing - Insights

Learn more about our Special Coagulation Laboratory and its algorithmic approaches to thrombophilia testing.

Tools for Laboratory Management - Insights

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Robert Michel, editor-in-chief of The Dark Report, an intelligence service and publication that provides economic and strategic assessment of the clinical...

Hematology, oncology, and hereditary test selection guide - Insights

The Hematology, Oncology, and Hereditary Test Selection Guide lets you search our next-generation sequencing test menu and choose the right panels for patients.

New pharmacogenetics program helps St. Clair Health improve patient care - Insights

Partnering with Mayo Clinic has helped St. Clair Health improve patient care and gain a new competitive advantage in pharmacogenetics.